Cushing Asset Management, LP Aerie Pharmaceuticals Inc Transaction History

Cushing Asset Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $483,460 - $918,023	-68,869 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $15,644 - $22,982	1,382 Added 2.05%	68,869 $785,000
Q2 2021 Aug 16, 2021	SELL	$15.16 - $18.97 $11,354 - $14,208	-749 Reduced 1.1%	67,487 $1.08 Million
Q1 2021 May 17, 2021	BUY	$13.12 - $20.9 $631,937 - $1.01 Million	48,166 Added 239.99%	68,236 $1.22 Million
Q4 2020 Feb 16, 2021	SELL	$9.12 - $14.49 $251,894 - $400,213	-27,620 Reduced 57.92%	20,070 $271,000
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $36,986 - $51,130	3,536 Added 8.01%	47,690 $561,000
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $119,544 - $160,687	9,962 Added 29.14%	44,154 $652,000
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $404,833 - $872,579	34,192 New	34,192 $462,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Cushing Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cushing Asset Management, LP with notifications on news.